1. INTRODUCTION

The Board of Directors of JcbNext Berhad (“JCBNEXT” or “the Company”) wishes to announce that the Company has on 19 January 2026, via acceptance of the unconditional mandatory take-over offer by Southern Score Builders Berhad to acquire all the remaining ordinary shares in Nova Pharma Solutions Berhad (“Nova Pharma”) for a cash consideration of RM0.37 per offer share, disposed of 14,084,507 ordinary shares representing a 9.45% equity interest in Nova Pharma, for a total cash consideration of RM5,211,268 (“Disposal”). 

Pursuant to Paragraph 9.19(26) of the Main Market Listing Requirements of Bursa Malaysia Securities Berhad (“Bursa Securities”), the Board wishes to announce that JCBNEXT had on 19 January 2026, ceased to be a substantial shareholder of Nova Pharma following the Disposal.

2. DETAILS OF THE DISPOSAL 

2.1 Information on Nova Pharma

Nova Pharma is a public company incorporated in Malaysia and listed on the LEAP Market of Bursa Securities. 

Nova Pharma is principally engaged in the business of provision of technical documentation, validation and project execution in the pharmaceutical and biological industries.

As at 19 January 2026, the issued ordinary share capital of Nova Pharma is RM7,985,000 comprising 149,009,057 ordinary shares.

2.2 Basis and justification at arriving at the Disposal Consideration 

The Disposal Consideration is based on the offer price of RM0.37 per ordinary share under the unconditional mandatory take-over offer by Southern Score Builders Berhad (“the Offeror”) to acquire all the remaining ordinary shares in Nova Pharma not already held by the Offeror and persons acting in concert with it, as stipulated in the Offer Document dated 12 January 2026.

3. DIRECTORS’ AND MAJOR SHAREHOLDERS’ INTEREST AND/OR PERSONS CONNECTED WITH THEM

None of the directors and/or major shareholders of the Company and/or persons connected to them have any interest, direct or indirect, in the Disposal.

4. STATEMENT BY THE BOARD OF DIRECTORS

The Board of Directors of JCBNEXT, after considering all the relevant factors, is of the opinion that the Disposal is in the best interest of JCBNEXT.

This announcement is dated 19 January 2026.